Huntsman [HUN] vs Asp Isotopes [ASPI] Detailed Stock Comparison
Huntsman
NYSE
Loading...
Asp Isotopes
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Huntsman wins in 11 metrics, Asp Isotopes wins in 7 metrics, with 0 ties. Huntsman appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Huntsman | Asp Isotopes | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 46.18 | -14.17 | Asp Isotopes |
| Price-to-Book Ratio | 0.54 | 15.14 | Huntsman |
| Debt-to-Equity Ratio | 74.27 | 84.08 | Huntsman |
| PEG Ratio | 10.96 | -59.53 | Asp Isotopes |
| EV/EBITDA | 10.39 | -23.83 | Asp Isotopes |
| Profit Margin (TTM) | -2.63% | 38.60% | Asp Isotopes |
| Operating Margin (TTM) | 0.64% | -721.89% | Huntsman |
| EBITDA Margin (TTM) | 0.64% | N/A | N/A |
| Return on Equity | -2.19% | -115.46% | Huntsman |
| Return on Assets (TTM) | 0.81% | -26.14% | Huntsman |
| Free Cash Flow (TTM) | $79.00M | $-28.07M | Huntsman |
| 1-Year Return | -59.03% | 313.43% | Asp Isotopes |
| Price-to-Sales Ratio (TTM) | 0.27 | 185.28 | Huntsman |
| Enterprise Value | $3.93B | $666.51M | Huntsman |
| EV/Revenue Ratio | 0.66 | 151.29 | Huntsman |
| Gross Profit Margin (TTM) | 14.26% | 29.67% | Asp Isotopes |
| Revenue per Share (TTM) | $35 | $0 | Huntsman |
| Earnings per Share (Diluted) | $-0.78 | $-0.59 | Asp Isotopes |
| Beta (Stock Volatility) | 0.72 | 3.38 | Huntsman |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Huntsman vs Asp Isotopes Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Huntsman | -5.05% | -17.69% | -16.73% | -31.11% | -43.01% | -47.19% |
| Asp Isotopes | -1.54% | -14.71% | 27.57% | 65.37% | 55.30% | 80.77% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Huntsman | -59.03% | -68.15% | -53.48% | -46.89% | -11.70% | -57.36% |
| Asp Isotopes | 313.43% | 218.93% | 218.93% | 218.93% | 218.93% | 218.93% |
Performance & Financial Health Analysis: Huntsman vs Asp Isotopes
| Metric | HUN | ASPI |
|---|---|---|
| Market Information | ||
| Market Cap | $1.60B | $816.25M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 6,035,103 | 4,793,356 |
| 90 Day Avg. Volume | 4,815,691 | 4,457,119 |
| Last Close | $9.21 | $8.93 |
| 52 Week Range | $9.03 - $25.12 | $1.86 - $10.82 |
| % from 52W High | -63.34% | -17.47% |
| All-Time High | $41.65 (Feb 21, 2022) | $10.82 (Jul 25, 2025) |
| % from All-Time High | -77.89% | -17.47% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.04% | 0.31% |
| Quarterly Earnings Growth | N/A | 0.31% |
| Financial Health | ||
| Profit Margin (TTM) | -0.03% | 0.39% |
| Operating Margin (TTM) | 0.01% | -7.22% |
| Return on Equity (TTM) | -0.02% | -1.15% |
| Debt to Equity (MRQ) | 74.27 | 84.08 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $17.10 | $0.59 |
| Cash per Share (MRQ) | $1.92 | $0.75 |
| Operating Cash Flow (TTM) | $254.00M | $-16,894,872 |
| Levered Free Cash Flow (TTM) | $150.62M | $-20,013,620 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Huntsman vs Asp Isotopes
| Metric | HUN | ASPI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 46.18 | -14.17 |
| Forward P/E | 10.96 | -59.53 |
| PEG Ratio | 10.96 | -59.53 |
| Price to Sales (TTM) | 0.27 | 185.28 |
| Price to Book (MRQ) | 0.54 | 15.14 |
| Market Capitalization | ||
| Market Capitalization | $1.60B | $816.25M |
| Enterprise Value | $3.93B | $666.51M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.66 | 151.29 |
| Enterprise to EBITDA | 10.39 | -23.83 |
| Risk & Other Metrics | ||
| Beta | 0.72 | 3.38 |
| Book Value per Share (MRQ) | $17.10 | $0.59 |
Financial Statements Comparison: Huntsman vs Asp Isotopes
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HUN | ASPI |
|---|---|---|
| Revenue/Sales | $1.41B | $1.10M |
| Cost of Goods Sold | $1.21B | $774,765 |
| Gross Profit | $201.00M | $326,840 |
| Research & Development | $32.00M | $1.53M |
| Operating Income (EBIT) | $10.00M | $-7.95M |
| EBITDA | $83.00M | $-8.23M |
| Pre-Tax Income | $27.00M | $-8.53M |
| Income Tax | $15.00M | $-70,720 |
| Net Income (Profit) | $11.00M | $-8.46M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HUN | ASPI |
|---|---|---|
| Cash & Equivalents | $334.00M | $55.97M |
| Total Current Assets | $2.29B | $59.03M |
| Total Current Liabilities | $1.54B | $8.18M |
| Long-Term Debt | $2.01B | $36.96M |
| Total Shareholders Equity | $3.17B | $45.73M |
| Retained Earnings | $2.19B | $-64.62M |
| Property, Plant & Equipment | $2.88B | $1.02M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HUN | ASPI |
|---|---|---|
| Operating Cash Flow | $-124.00M | $-7.16M |
| Capital Expenditures | N/A | $-2.36M |
| Free Cash Flow | $-110.00M | $-5.53M |
| Debt Repayment | $-319.00M | $-262,304 |
| Common Stock Repurchase | $0 | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | HUN | ASPI |
|---|---|---|
| Shares Short | 9.04M | 16.34M |
| Short Ratio | 2.12 | 4.67 |
| Short % of Float | 0.06% | 0.24% |
| Average Daily Volume (10 Day) | 6,035,103 | 4,793,356 |
| Average Daily Volume (90 Day) | 4,815,691 | 4,457,119 |
| Shares Outstanding | 172.14M | 72.07M |
| Float Shares | 153.89M | 54.53M |
| % Held by Insiders | 0.06% | 0.23% |
| % Held by Institutions | 0.89% | 0.37% |
Dividend Analysis & Yield Comparison: Huntsman vs Asp Isotopes
| Metric | HUN | ASPI |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.46 | N/A |
| 3-Year Avg Dividend Yield | 0.88% | N/A |
| 3-Year Total Dividends | $1.38 | N/A |
| Ex-Dividend Date | Dec 14, 2023 | N/A |